MedTrace Logo

Management of Bleeding Following Cardiopulmonary Bypass

NCT00672516 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2015-05-28

No results posted yet for this study

Summary

We believe ongoing bleeding during complex cardiac surgery can be accurately measured and that administration of a specific blood product replacement strategy designed to optimally slow or stop the bleeding can be followed by the during the operation.

Patients at risk of significant bleeding after complex cardiac surgery will be approached to allow their operation to be watched by study personnel to see if ongoing blood loss can be accurately measured and to see how quickly a prescribed, standardized blood product replacement protocol to control the bleeding does slow or stop the bleeding. Permission to review the medical record to see if bleeding risk features can be identified and permission to follow the patient after surgery to see how they recover is also requested.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Marie E Steiner, MD, MS · University of Minnesota

  • Philip Greilich, MD · University of Texas Souwthwestern Medical Center

  • Nauder Faraday, MD · Johns Hopkins Medical Center

  • Nigel S Key, MB, FRCP · University of North Carolina, Chapel Hill

  • Jerrold Levy, MD · Emory University

Eligibility

Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00672516 on ClinicalTrials.gov